Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric symptoms with long-COVID in Japan
Y Noda, A Sato, M Shichi, A Sato, K Fujii… - Asian Journal of …, 2023 - Elsevier
The number of patients suffering from long-COVID is currently increasing rapidly, even after
the acute symptoms of COVID-19 have improved. The objective of this study was to …
the acute symptoms of COVID-19 have improved. The objective of this study was to …
Evaluating real-world effectiveness of accelerated transcranial magnetic stimulation for treatment-resistant depression in a tertiary referral center based in Quebec …
Objective To assess the effectiveness of accelerated transcranial magnetic stimulation
(TMS) for treatment-resistant depression (TRD) in a tertiary referral center in Quebec …
(TMS) for treatment-resistant depression (TRD) in a tertiary referral center in Quebec …
A Retrospective Case–Control Study on the Differences in the Effectiveness of Theta-Burst Stimulation Therapy for Depression with and without Antidepressant …
H Ikawa, Y Takeda, R Osawa, A Sato, H Mizuno… - Journal of Clinical …, 2024 - mdpi.com
Transcranial magnetic stimulation (TMS) therapy has few side effects and comparable
therapeutic effects to antidepressant treatment, but few studies have introduced TMS therapy …
therapeutic effects to antidepressant treatment, but few studies have introduced TMS therapy …
Real-world retrospective study of repetitive transcranial magnetic stimulation (TMS) treatment for bipolar and unipolar depression using TMS registry data in Tokyo
H Ikawa, R Osawa, Y Takeda, A Sato, H Mizuno… - Heliyon, 2024 - cell.com
Despite the prevalence of empirical practice, evidence supporting the use of repetitive
transcranial magnetic stimulation (rTMS) in treating bipolar depression (BD) is sparse …
transcranial magnetic stimulation (rTMS) in treating bipolar depression (BD) is sparse …
Évaluation de l'efficacité de la stimulation magnétique transcrânienne accélérée pour la dépression réfractaire dans une clinique de troisième ligne au Québec
C Massé-Leblanc - 2023 - papyrus.bib.umontreal.ca
Environ 300 millions de personnes dans le monde souffrent de dépression et environ 30%
vont développer une dépression réfractaire. Une dépression est réfractaire quand deux …
vont développer une dépression réfractaire. Une dépression est réfractaire quand deux …